|
1
|
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JC, Crippa JA, Zuardi AW, Mechoulam R, Guimarães FS. Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS One 2016; 11:e0162087. [PMID: 27560809 PMCID: PMC4999303 DOI: 10.1371/journal.pone.0162087] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
|
2
|
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JC, Crippa JA, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. PLoS One 2016; 11:e0158779. [PMID: 27416026 PMCID: PMC4945002 DOI: 10.1371/journal.pone.0158779] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2016] [Accepted: 06/21/2016] [Indexed: 12/31/2022] Open
Abstract
Cannabidiol (CBD) is a major Cannabis sativa constituent, which does not cause the typical marijuana psychoactivity. However, it has been shown to be active in a numerous pharmacological assays, including mice tests for anxiety, obsessive-compulsive disorder, depression and schizophrenia. In human trials the doses of CBD needed to achieve effects in anxiety and schizophrenia are high. We report now the synthesis of 3 fluorinated CBD derivatives, one of which, 4'-F-CBD (HUF-101) (1), is considerably more potent than CBD in behavioral assays in mice predictive of anxiolytic, antidepressant, antipsychotic and anti-compulsive activity. Similar to CBD, the anti-compulsive effects of HUF-101 depend on cannabinoid receptors.
Collapse
Affiliation(s)
- Aviva Breuer
- Institute for Drug Research, Medical Faculty, Hebrew University, Jerusalem, Israel
| | - Christeene G. Haj
- Institute for Drug Research, Medical Faculty, Hebrew University, Jerusalem, Israel
| | - Manoela V. Fogaça
- Departments of Pharmacology, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
| | - Felipe V. Gomes
- Departments of Pharmacology, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
| | - Nicole Rodrigues Silva
- Departments of Pharmacology, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
| | - João Francisco Pedrazzi
- Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
| | - Elaine A. Del Bel
- Department of Morphology, Physiology and Pathology, School of Odontology of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
| | - Jaime C. Hallak
- Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
| | - José A. Crippa
- Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
| | - Antonio W. Zuardi
- Neuroscience and Behavior, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
| | - Raphael Mechoulam
- Institute for Drug Research, Medical Faculty, Hebrew University, Jerusalem, Israel
- * E-mail: (RM); (FSG)
| | - Francisco S. Guimarães
- Departments of Pharmacology, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil
- * E-mail: (RM); (FSG)
| |
Collapse
|